Pivarubicin Is More Effective Than Doxorubicin Against Triple-Negative Breast Cancer In Vivo.

Oncol Res · 2020 · PMC7751225 · PMID 32430093

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may not be significantno p-value reported

Given the marginal histological evidence of cardiotoxicity with doxorobucin in our studies, the differences in cardiotoxicity between vehicle and doxorubicin may not be significant.

also in 2,774 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.